FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134328654> ?p ?o ?g. }

• W2134328654 abstract "BACKGROUND: A study for pain relief therapy with 188Re-HEDP was done in patients with bone metastases secondary to breast and prostate cancer. MATERIALS AND METHODS: Patients received 1.3 or 2.2 GBq, in single or multiple doses. Platelets, white and red cells were evaluated during 11 weeks. Pharmacokinetic characterization was done from blood and urine samples for 5 patients along 24 hours. Urinary excretion was evaluated in other 16 patients during 6 hours. Bone uptake was estimated as remaining activity in whole body. Scintigraphic images were acquired at 2 and 24 hs post-administration. Absorbed dose in bone marrow was estimated with Mirdose3. Analgesics intake and pain score were daily recorded. Tumour markers (PSA, and Tn-structure) were monitored in 9 patients during 4 to 6 months. Single doses of low activity (1.3 GBq) were given to twelve patients. Nine patients received multiple doses. RESULTS: All except one patient had normal levels of platelets, white and red cells. Remaining dose in blood at 2 hours was 9%. Urinary elimination was 58%. Bone uptake at 24 hours was 43% (mean value; n = 5). No changes of the haematological parameters were detected along follow-up period. Pain relief was evidenced by decrease or supression of opioid analgesic and by subjective index. PSA showed a decrease in prostate cancer patients (n = 4). Tn-structure showed a significant increase after 4 to 8 months. CONCLUSION: Single or multiple dose scheme could be safely used, with administered activity of 188Re-HEDP up to 60 mCi, with low bone marrow absorbed doses." @default.
• W2134328654 created "2016-06-24" @default.
• W2134328654 creator A5006909823 @default.
• W2134328654 creator A5014064428 @default.
• W2134328654 creator A5018769034 @default.
• W2134328654 creator A5021882662 @default.
• W2134328654 creator A5027594340 @default.
• W2134328654 creator A5028070047 @default.
• W2134328654 creator A5035448829 @default.
• W2134328654 creator A5065726696 @default.
• W2134328654 creator A5077544336 @default.
• W2134328654 creator A5081855858 @default.
• W2134328654 creator A5090545095 @default.
• W2134328654 date "2001-11-21" @default.
• W2134328654 modified "2023-10-10" @default.
• W2134328654 title "Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose" @default.
• W2134328654 cites W1491212204 @default.
• W2134328654 cites W1799563891 @default.
• W2134328654 cites W1805060424 @default.
• W2134328654 cites W1812289676 @default.
• W2134328654 cites W1833947020 @default.
• W2134328654 cites W1898092403 @default.
• W2134328654 cites W1911330355 @default.
• W2134328654 cites W1926518917 @default.
• W2134328654 cites W1953800255 @default.
• W2134328654 cites W1983514189 @default.
• W2134328654 cites W1988369394 @default.
• W2134328654 cites W1999374255 @default.
• W2134328654 cites W2004590041 @default.
• W2134328654 cites W2021647329 @default.
• W2134328654 cites W2032217270 @default.
• W2134328654 cites W2037282660 @default.
• W2134328654 cites W2059342531 @default.
• W2134328654 cites W2062587636 @default.
• W2134328654 cites W2068642999 @default.
• W2134328654 cites W2068775401 @default.
• W2134328654 cites W2097669123 @default.
• W2134328654 cites W2103227635 @default.
• W2134328654 cites W2106595936 @default.
• W2134328654 cites W2126177095 @default.
• W2134328654 cites W2158438423 @default.
• W2134328654 cites W2185891517 @default.
• W2134328654 cites W2325487157 @default.
• W2134328654 cites W2346874390 @default.
• W2134328654 cites W2412304292 @default.
• W2134328654 cites W2485238259 @default.
• W2134328654 cites W286106976 @default.
• W2134328654 doi "https://doi.org/10.1186/1471-2385-1-2" @default.
• W2134328654 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/60657" @default.
• W2134328654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11734069" @default.
• W2134328654 hasPublicationYear "2001" @default.
• W2134328654 type Work @default.
• W2134328654 sameAs 2134328654 @default.
• W2134328654 citedByCount "31" @default.
• W2134328654 countsByYear W21343286542012 @default.
• W2134328654 countsByYear W21343286542013 @default.
• W2134328654 countsByYear W21343286542014 @default.
• W2134328654 countsByYear W21343286542016 @default.
• W2134328654 countsByYear W21343286542017 @default.
• W2134328654 countsByYear W21343286542018 @default.
• W2134328654 countsByYear W21343286542019 @default.
• W2134328654 countsByYear W21343286542020 @default.
• W2134328654 countsByYear W21343286542021 @default.
• W2134328654 countsByYear W21343286542022 @default.
• W2134328654 countsByYear W21343286542023 @default.
• W2134328654 crossrefType "journal-article" @default.
• W2134328654 hasAuthorship W2134328654A5006909823 @default.
• W2134328654 hasAuthorship W2134328654A5014064428 @default.
• W2134328654 hasAuthorship W2134328654A5018769034 @default.
• W2134328654 hasAuthorship W2134328654A5021882662 @default.
• W2134328654 hasAuthorship W2134328654A5027594340 @default.
• W2134328654 hasAuthorship W2134328654A5028070047 @default.
• W2134328654 hasAuthorship W2134328654A5035448829 @default.
• W2134328654 hasAuthorship W2134328654A5065726696 @default.
• W2134328654 hasAuthorship W2134328654A5077544336 @default.
• W2134328654 hasAuthorship W2134328654A5081855858 @default.
• W2134328654 hasAuthorship W2134328654A5090545095 @default.
• W2134328654 hasBestOaLocation W21343286541 @default.
• W2134328654 hasConcept C10146269 @default.
• W2134328654 hasConcept C112705442 @default.
• W2134328654 hasConcept C121608353 @default.
• W2134328654 hasConcept C126322002 @default.
• W2134328654 hasConcept C126894567 @default.
• W2134328654 hasConcept C141071460 @default.
• W2134328654 hasConcept C2776139714 @default.
• W2134328654 hasConcept C2776235491 @default.
• W2134328654 hasConcept C2777783956 @default.
• W2134328654 hasConcept C2780026642 @default.
• W2134328654 hasConcept C2780192828 @default.
• W2134328654 hasConcept C2989005 @default.
• W2134328654 hasConcept C71924100 @default.
• W2134328654 hasConcept C77411442 @default.
• W2134328654 hasConceptScore W2134328654C10146269 @default.
• W2134328654 hasConceptScore W2134328654C112705442 @default.
• W2134328654 hasConceptScore W2134328654C121608353 @default.
• W2134328654 hasConceptScore W2134328654C126322002 @default.
• W2134328654 hasConceptScore W2134328654C126894567 @default.
• W2134328654 hasConceptScore W2134328654C141071460 @default.
• W2134328654 hasConceptScore W2134328654C2776139714 @default.
• W2134328654 hasConceptScore W2134328654C2776235491 @default.

• next